I really do appreciate all the knowledge of this board's followers and contributors, but I have a lot invested in this stock and all I really want to know is how and if we will all get our money back or more. thanks
idcc, what am I wrong about? Knuts mentioned R/A/RC's Nilvad trial and I provided a comment.
I know RC's anatabine is not focused on beta-amyloid. I have mentioned previously that I hope Anavex would use anatabine citrate and its anti-inflammation mechanism with Anavex's 2-73 drug ... I think that would be a real winner against AD and probably other CNS diseases.